Inactive Instrument

PUF Ventures Inc Share Price Canadian Securities Exchange

Equities

CA74530Q2053

Healthcare Facilities & Services

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 0.67 0.92 56.07 Sales 2023 - Capitalization 2L 2L 1.49Cr
Net income 2022 -4.1Cr -5.58Cr -341.37Cr Net income 2023 1.7Cr 2.31Cr 141.54Cr EV / Sales 2022 2,78,12,179 x
Net Debt 2022 1.77Cr 2.4Cr 146.98Cr Net Debt 2023 4L 6L 3.42Cr EV / Sales 2023 -
P/E ratio 2022
-0.01 x
P/E ratio 2023
0.01 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 95.91%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 45 07/22/07
Director of Finance/CFO - 01/21/01
Members of the board TitleAgeSince
Director of Finance/CFO - 01/21/01
Chief Executive Officer 45 07/22/07
Director/Board Member - -
More insiders
Digicann Ventures Inc., formerly Agra Ventures Ltd., is a Canada-based diversified company focused on the international cannabis industry. The Company is engaged in the cultivation, distribution and marketing of cannabis and cannabis-infused products around the world. It has a portfolio of licensed upstream, downstream, and product formulation assets. Its primary asset in Canada is Boundary Bay Cannabis, a cannabis greenhouse facility focused on the cultivation of high-potency cannabis. The Company's wholly owned subsidiary, Farmako GmbH (Farmako), is a distributor of medical cannabis. Farmako distributes the products in its network of German pharmacies. Its products have Farmako's branding. The products initially include high potency tetrahydrocannabinol (THC) flower and balanced THC and cannabidiol (CBD) flower. Farmako has product distribution operations in Germany and in the United Kingdom.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW